Skip to content
10-Q

Quarterly Report

Bionano Genomics, Inc. BNGO

0001411690-26-000028

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 6, 2026 11.48M sh
Shares Diluted Q1 2026 · Mar 31, 2026 10.98M sh
Shares Diluted Q1 2026 · Mar 31, 2025 2.69M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$5.72M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$2.76M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $3.43M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $2.99M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $3.63M
Stockholders Equity Q1 2026 · Mar 31, 2026 $37.46M
Stockholders Equity Q1 2026 · Dec 31, 2025 $44.42M
Stockholders Equity Q1 2026 · Mar 31, 2025 $48.19M
Stockholders Equity Q1 2026 · Dec 31, 2024 $35.38M
Current Liabilities Q1 2026 · Mar 31, 2026 $21.23M
Current Liabilities Q1 2026 · Dec 31, 2025 $22.94M
Total Liabilities Q1 2026 · Mar 31, 2026 $27.34M
Total Liabilities Q1 2026 · Dec 31, 2025 $29.16M
Current Assets Q1 2026 · Mar 31, 2026 $38.98M
Current Assets Q1 2026 · Dec 31, 2025 $45.39M
Total Assets Q1 2026 · Mar 31, 2026 $64.8M
Total Assets Q1 2026 · Dec 31, 2025 $73.58M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.76
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.15
Eps Basic Q1 2026 · Mar 31, 2026 −$0.76
Eps Basic Q1 2026 · Mar 31, 2025 −$1.15
Sga Expense Q1 2026 · Mar 31, 2026 $8.01M
Sga Expense Q1 2026 · Mar 31, 2025 $9.03M
Rd Expense Q1 2026 · Mar 31, 2026 $3.14M
Rd Expense Q1 2026 · Mar 31, 2025 $2.37M
Net Income Q1 2026 · Mar 31, 2026 −$8.3M
Net Income Q1 2026 · Mar 31, 2025 −$3.1M
Operating Income Q1 2026 · Mar 31, 2026 −$7.9M
Operating Income Q1 2026 · Mar 31, 2025 −$8.47M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $3.44M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $3.52M
Revenue Q1 2026 · Mar 31, 2026 $6.69M
Revenue Q1 2026 · Mar 31, 2025 $6.46M